Method to inhibit restenosis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/40 (2006.01) A61K 9/127 (2006.01)

Patent

CA 2168043

A pharmaceutical composition to inhibit the development of intimal hyperplasia following vascular (angioplasty) is disclosed. The pharmaceutical composition contains green porphyrin and is administered to the subject concurrent with and following the angioplasty. No purposeful irradiation with light absorbed by the green porphyrin is required or employed with the composition.

L'invention concerne une composition pharmaceutique destinée à inhiber le développement d'une hyperplasie de l'intima à la suite de procédures d'intervention vasculaire (angioplastie). Cette composition contient de la porphyrine verte et est administrée au sujet pendant et après une angioplastie. Aucune irradiation intentionnelle avec une lumière absorbée par la porphyrine verte ne s'impose ou ne s'emploie avec cette composition.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method to inhibit restenosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method to inhibit restenosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to inhibit restenosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2060686

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.